LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 75 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,000 | -66.7% | 333 | -43.9% | 0.00% | – |
Q1 2022 | $3,000 | -92.1% | 594 | -92.7% | 0.00% | – |
Q4 2021 | $38,000 | +3700.0% | 8,127 | +2771.7% | 0.00% | – |
Q2 2021 | $1,000 | -96.4% | 283 | -95.7% | 0.00% | – |
Q1 2021 | $28,000 | +2700.0% | 6,632 | +2032.5% | 0.00% | – |
Q4 2020 | $1,000 | -94.4% | 311 | -92.5% | 0.00% | – |
Q1 2020 | $18,000 | +800.0% | 4,170 | +631.6% | 0.00% | – |
Q4 2019 | $2,000 | -94.1% | 570 | -84.3% | 0.00% | – |
Q2 2019 | $34,000 | +750.0% | 3,625 | +2400.0% | 0.00% | – |
Q2 2018 | $4,000 | -96.7% | 145 | -96.2% | 0.00% | -100.0% |
Q4 2017 | $123,000 | -16.3% | 3,814 | -10.0% | 0.00% | 0.0% |
Q3 2017 | $147,000 | -43.7% | 4,240 | -51.7% | 0.00% | -66.7% |
Q2 2017 | $261,000 | +507.0% | 8,780 | +381.9% | 0.00% | – |
Q3 2016 | $43,000 | -76.4% | 1,822 | -84.0% | 0.00% | -100.0% |
Q2 2016 | $182,000 | – | 11,380 | +227500.0% | 0.00% | – |
Q1 2016 | $0 | -100.0% | 5 | -99.4% | 0.00% | – |
Q4 2015 | $22,000 | -94.0% | 805 | -93.9% | 0.00% | -100.0% |
Q3 2015 | $366,000 | +2.5% | 13,188 | -9.5% | 0.01% | 0.0% |
Q2 2015 | $357,000 | – | 14,577 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 4,138,893 | $123,256,000 | 18.11% |
Broadfin Capital, LLC | 1,656,720 | $49,337,000 | 7.69% |
SECTORAL ASSET MANAGEMENT INC | 1,128,219 | $33,598,000 | 3.68% |
Perceptive Advisors | 4,313,611 | $128,459,000 | 3.60% |
RTW INVESTMENTS, LP | 1,122,540 | $33,429,000 | 3.18% |
Asymmetry Capital Management, L.P. | 55,864 | $1,664,000 | 2.08% |
EMORY UNIVERSITY | 77,335 | $2,303,000 | 1.64% |
Monashee Investment Management LLC | 185,000 | $5,509,000 | 1.52% |
SPHERA FUNDS MANAGEMENT LTD. | 260,000 | $7,743,000 | 1.18% |
Stanley-Laman Group, Ltd. | 167,825 | $4,998,000 | 1.14% |